![Memorial Sloan Kettering medical oncologist Neil Shah](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/184558/3x2/shah-neil_191112_11_1200x800.jpg?h=10d202d3)
Neil J. Shah, MBBS
Genitourinary Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Kidney Cancer (Renal Cell Carcinoma)
- Genitourinary Malignancies
- Immunotherapy
Request an Appointment
About Me
- Assistant Attending Physician
I am a medical oncologist with a strong interest and extensive training in treating genitourinary cancers. This includes taking care of people with kidney, prostate, bladder, and testicular cancers.
I work with a multidisciplinary team of surgeons, interventional radiologists, radiation oncologists, and pathologists to provide cutting-edge treatment for each patient. In addition to standard-of-care treatments, we can offer our patients many innovative clinical trials options.
Read more
My primary area of interest is to identify novel treatments for people with kidney cancer. I am an active member of the translation kidney cancer research program at MSK. I am also interested in the development of novel methods for early detection of toxicity from immunotherapy treatment.
I strongly believe that over the next few decades, advances in the field of cancer immunology and genetics could help us cure cancer in nearly every patient and I am determined to lead these advances.
A genitourinary (jeh-nih-toh-YOOR-ih-nayr-ee) oncologist is a cancer doctor with special training in the genitourinary (GU) system. This includes bladder, kidney, penis, prostate, and testicular cancers.
My Specialties
- Kidney Cancer (Renal Cell Carcinoma)
- Genitourinary Malignancies
- Immunotherapy
- Clinical Informatics, Real-World Outcomes
- Big Data in Oncology
Education
- MBBS, Pramukhswami Medical College, India
Residencies
- Internal Medicine - Hackensack Meridian Health Mountainside Medical Center
Awards and Honors
- Invited Member, ASCO/AACR Methods in Clinical Cancer Research Workshop (2018)
Fellowships
- Hematology/Oncology - MedStar Georgetown University Hospital
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Shah sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
- Clinical Trials Investigated by Dr. Shah
- A Phase 1b Study of HC-7366 and Belzutifan in People With Advanced Kidney Cancer
- Clinical Trials Co-Investigated by Dr. Shah
- A Study to Learn More About Skin Reactions to Cancer Immunotherapy
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Neil J. Shah discloses the following relationships and financial interests:
-
Aravive, Inc.
Professional Services and Activities -
Exelixis
Professional Services and Activities -
MedNet
Professional Services and Activities
-
Merck & Co Inc.
Professional Services and Activities -
Targeted Oncology
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].